Clinical Trials on Non Valvular Atrial Fibrillation (nv AF)

Total 762 results

Assistance Publique - Hôpitaux de Paris

Unknown

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF) (Presage-Aco)

Non Valvular Atrial Fibrillation (nv AF)
Boston Scientific Corporation

Recruiting

Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)

Denmark
Assiut University

Unknown

Demographic Outcomes, and Health Care Resources in Newly Diagnosed Non Valvular AF Patients

Non Valvular AF ,AF

Egypt
The First Affiliated Hospital of Xiamen University

Recruiting

Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

AF - Atrial Fibrillation | HTN-Hypertension

China
Cardiovascular Innovation and Research Institute
Valley View Hospital

Recruiting

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

Coronary Artery Disease | Atrial Fibrillation (AF)

United States
Bayer

Completed

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. (PACIFIC-AF)

Atrial Fibrillation (AF)

Spain, Belgium, Latvia, Italy, Switzerland, Canada, Austria, Japan, Czechia, Hungary, Netherlands, Sweden, France, United Kingdom
University Hospital, Basel, Switzerland
Boston Scientific Corporation

Completed

Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O (CHAZESubstrate)

Atrial Fibrillation (AF)

Switzerland
AtriCure, Inc.

Active, not recruiting

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment (ICE-AFIB)

Persistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial Fibrillation

United States
Assiut University

Not yet recruiting

the Role of Ivabradine in Causing AF in Patients With Chronic Coronary Syndrome

AF - Atrial Fibrillation
Anthos Therapeutics, Inc.
Laboratory Corporation of America; The TIMI Study Group

Active, not recruiting

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)

Stroke | Atrial Fibrillation (AF)

United States, Canada, Czechia, Hungary, Korea, Republic of, Poland, Taiwan
Anthos Therapeutics, Inc.

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (LILAC-TIMI 76)

Atrial Fibrillation (AF)

United States, Canada, Israel, Japan, China, Brazil, Chile, United Kingdom, Bulgaria, Germany, Hungary, Italy, Poland, Romania, Spain, Czechia, Latvia, Mexico
Northwestern University
Cardiovascular Institute of the South Clinical Research Corporation

Enrolling by invitation

KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation

Atrial Fibrillation (AF)

United States
University Hospital, Basel, Switzerland

Completed

Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation

Atrial Fibrillation (AF)

Switzerland
Maria Cecilia Hospital

Completed

Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop (CryoLID)

Atrial Fibrillation (AF)

Italy
Ain Shams University

Completed

Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study

AF - Atrial Fibrillation

Egypt
University Hospital, Toulouse

Completed

Medical and Surgical Hybrid Treatment of Atrial Fibrillation. (HT2AF)

Atrial Fibrillation (AF)

France
University Hospital, Clermont-Ferrand
Groupama foundation; Biochemistry Lab University Hospital Clermont-Ferrand

Recruiting

Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation (PROFIB-AF)

Women and Men Over 18 Years Old | AF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AF | Able to Give His Non Opposition to Participate to the Study

France
Utrecht Institute for Pharmaceutical Sciences
Uppsala University; Erasmus Medical Center; Newcastle University; University of... and other collaborators

Completed

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon (EU-PACT)

Venous Thromboembolism (VTE) | Atrial Fibrillation (AF)

Germany, Austria, Netherlands
Royal Brompton & Harefield NHS Foundation Trust
Baylis Medical Company

Unknown

Non-fluoroscopy Ablation of AF/AT (ZERO-AF)

Atrial Tachycardia | AF - Atrial Fibrillation

United Kingdom
Asklepios proresearch
Atrial Fibrillation Network; Medtronic Bakken Research

Recruiting

From the Emergency Department Directly to Ablation of Atrial Fibrillation Study (EMERGE Cryo)

Atrial Fibrillation (AF)

Germany
Advanced Cooling Therapy, Inc., d/b/a Attune Medical
University of Colorado, Denver; University of Pennsylvania; Beth Israel Deaconess... and other collaborators

Recruiting

Oesophageal Protection Study: A Multicentre Study. (IMPACT II)

Complication | AF - Atrial Fibrillation | Atrio-Esophageal Fistula

United States, United Kingdom
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb

Completed

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

Non-valvular Atrial Fibrillation

United States
Jena University Hospital

Recruiting

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. (CLEARANCE)

Atrial Fibrillation (AF) | Intracranial Bleed

Germany
Biosense Webster, Inc.

Completed

CARTO® 3 System and Real Time Intracardiac Ultrasound (IUAF)

Atrial Fibrillation | Paroxysmal AF

United States
Insel Gruppe AG, University Hospital Bern
Sahajanand Medical Technologies Limited

Recruiting

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation (MATRIX-2)

Atrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 Inhibitor

Spain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
Xijing Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Not yet recruiting

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology (RECORD)

Non-valvular Atrial Fibrillation

China
Bayer
Janssen Research & Development, LLC

Completed

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment (RITMUS-AF)

Non-valvular Atrial Fibrillation

Italy
Daiichi Sankyo, Inc.
Daiichi Sankyo (China) Holdings Co., Ltd.

Active, not recruiting

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China (ETNA-AF-CHINA)

Non-valvular Atrial Fibrillation

China
Saint Luke's Health System
Bristol-Myers Squibb; AliveCor

Completed

Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm (BOAT OAR)

Non-valvular Atrial Fibrillation

United States
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Non-valvular Atrial Fibrillation

Japan
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists (ANTENNA)

Non-Valvular Atrial Fibrillation

United Kingdom
Bristol-Myers Squibb

Completed

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) (AEGEAN)

Non-valvular Atrial Fibrillation

Belgium, France, Italy, Spain, Switzerland, Germany, United Kingdom
Bristol-Myers Squibb
IMS Health; OXON Epidemiology

Completed

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2 (REACT-AF2)

Non-valvular Atrial Fibrillation
Bristol-Myers Squibb

Completed

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

Non-Valvular Atrial Fibrillation
Cardia Inc.

Unknown

Canadian Left Atrial Appendage Closure Study (CLASS)

Non-Valvular Atrial Fibrillation | Left Atrial Appendage

Canada
Abbott Medical Devices

Recruiting

Amplatzer Amulet China Post Market Study (PMS)

Non-Valvular Atrial Fibrillation

China
Conformal Medical, Inc

Completed

The Conformal Prague Study

Non-valvular Atrial Fibrillation

Czechia
University Hospital, Montpellier

Completed

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program (MONACO)

Non-valvular Atrial Fibrillation

France
Bayer
Janssen Research & Development, LLC

Terminated

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients. (PROTECT-AF)

Non-valvular Atrial Fibrillation

Norway
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital

Recruiting

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Non-Valvular Atrial Fibrillation

China
Conformal Medical, Inc
Yale Cardiovascular Research Group

Active, not recruiting

The CONFORMAL Early Feasibility Study

Non-valvular Atrial Fibrillation

United States
Bristol-Myers Squibb

Completed

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation (ARISTOPHANES)

Non-Valvular Atrial Fibrillation

United States
Laminar, Inc.

Active, not recruiting

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Non-valvular Atrial Fibrillation

United States
Daiichi Sankyo, Inc.
Daiichi Sankyo Deutschland GmbH

Completed

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENCOURAGE-AF)

Non-valvular Atrial Fibrillation

Germany
Bristol-Myers Squibb

Withdrawn

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Non-valvular Atrial Fibrillation

United States
Boston Scientific Corporation
Iqvia Pty Ltd; Premier Research Group plc

Completed

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Non-valvular Atrial Fibrillation

Ireland, Germany, Denmark, France, Spain, United Kingdom, Italy, Netherlands, Poland
Bristol-Myers Squibb
Pfizer

Withdrawn

Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation

Non-valvular Atrial Fibrillation
University College, London

Completed

Clinical Relevance of Microbleeds In Stroke (CROMIS-2)

Stroke | Atrial Fibrillation (AF) | Intracerebral Haemorrhage (ICH)

United Kingdom
Vivek Reddy

Recruiting

LS-PersAFone: Pulsed Field Ablation for Long-Standing Persistent Atrial Fibrillation (LS-PersAFone)

Long-standing Persistent AF

United States

Clinical Trials on Non Valvular Atrial Fibrillation (nv AF)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations